{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06122987",
            "orgStudyIdInfo": {
                "id": "KRMC 0284"
            },
            "organization": {
                "fullName": "Kingman Regional Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock",
            "officialTitle": "An Open-label, Single-arm, Single-center Study Evaluating the Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock",
            "therapeuticArea": [
                "Infectious Diseases",
                "Other",
                "Immunology and Rheumatology"
            ],
            "study": "hemodynamic-response-to-angiotensin-ii-when-used-as-the-second-vasopressor-agent-for-septic-shock"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-03",
            "studyFirstSubmitQcDate": "2023-11-03",
            "studyFirstPostDateStruct": {
                "date": "2023-11-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Tyson Dietrich",
                "investigatorTitle": "Pharmacist",
                "investigatorAffiliation": "Kingman Regional Medical Center"
            },
            "leadSponsor": {
                "name": "Kingman Regional Medical Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "La Jolla Pharmaceutical Company",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "Norepinephrine is a catecholamine that is the first-line vasopressor for septic shock. The addition of non-catecholamine vasopressors, including vasopressin and angiotensin-II may be used in adults with septic shock that have inadequate mean arterial pressure while on norepinephrine. Uncertainty exists regarding the timing of initiation of these agents and there is a lack of data comparing their safety and efficacy.\n\nThe current literature suggests that earlier initiation of angiotensin-II will have a more significant reduction on norepinephrine-equivalent dose compared to later initiation. In addition, approximately half of patients initiated on vasopressin do not have an early hemodynamic response 6 hours after initiation. The purpose of this study is to evaluate the efficacy of angiotensin-II when used as the second vasopressor agent for septic shock.",
            "detailedDescription": "Objectives:\n\nPrimary Objective:\n\n1. To evaluate the efficacy of ang-II when used as the second vasopressor agent for septic shock\n\nSecondary Objectives:\n\n1. To assess the duration of response to ang-II\n2. To assess overall survival\n3. To assess the amount of time spent in the ICU\n4. To assess the need for renal replacement therapy\n5. To assess the overall duration of vasoactive medication use\n6. To assess toxicity and tolerability"
        },
        "conditionsModule": {
            "conditions": [
                "Septic Shock",
                "Shock",
                "Sepsis",
                "Systemic Inflammatory Response Syndrome"
            ],
            "keywords": [
                "Sepsis",
                "Angiotensin II",
                "Hydrocortisone"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Single Arm",
                    "type": "EXPERIMENTAL",
                    "description": "Drug: Angiotensin II Other Names: Giapreza",
                    "interventionNames": [
                        "Drug: Angiotensin II and hydrocortisone sodium succinate"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Angiotensin II and hydrocortisone sodium succinate",
                    "description": "Intravenous infusion angiotensin II (titrated for each individual patient by effect) and hydrocortisone 50 mg intravenous bolus every 6 hours.",
                    "armGroupLabels": [
                        "Single Arm"
                    ],
                    "otherNames": [
                        "Giapreza"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The incidence of hemodynamic response, defined as a decrease in norepinephrine-equivalent dose with a MAP \u226565 mm Hg at 1 hour after initiation of angiotensin-II",
                    "description": "Defined as a decrease in norepinephrine-equivalent dose with a MAP \u226565 mm Hg at 1 hour after initiation of angiotensin-II.",
                    "timeFrame": "1 hour"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "The incidence of hemodynamic response at 3 hours after initiation of angiotensin-II",
                    "description": "Defined as a decrease in norepinephrine-equivalent dose with a MAP \u226565 mm Hg at 3 hours after initiation of angiotensin-II.",
                    "timeFrame": "3 hours"
                },
                {
                    "measure": "The incidence of hemodynamic response at 6 hours after initiation of angiotensin-II",
                    "description": "Defined as a decrease in norepinephrine-equivalent dose with a MAP \u226565 mm Hg at 6 hours after initiation of angiotensin-II.",
                    "timeFrame": "6 hours"
                },
                {
                    "measure": "28-day mortality",
                    "description": "Defined as all cause mortality up to 28 days from study enrollment.",
                    "timeFrame": "28 days"
                },
                {
                    "measure": "ICU length of stay",
                    "description": "Defined as the time spent within the ICU until discharge to a step down unit.",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Need for renal replacement therapy",
                    "description": "Defined as patients started on either continuous renal replacement therapy (CRRT) or intermittent hemodialysis (IHD) during the study period.",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Vasoactive medication duration overall",
                    "description": "Defined as the duration (hours) of vasoactive medication use during the study period.",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Incidence of adverse reactions",
                    "description": "Define as an unexpected or unintended effect suspected to be caused by a medicine.",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients admitted to the ICU within 12 hours of presentation to the emergency department for septic shock requiring 15-25 mcg/min of norepinephrine. Septic shock will be defined as having a known or presumed infection with two or more criteria of systemic inflammatory response syndrome, a mean arterial pressure \\<65 mm Hg despite fluid resuscitation requiring vasopressor support, and a serum lactate \\>2 mmol/L. Criteria of systemic inflammatory response syndrome include a temperature \\>100.4\u00b0F or \\<96.8\u00b0F; heart rate \\>90/min; respiratory rate \\>20/min and a white blood cell count \\>12,000/mm3 or \\<4,000/mm3.\n\nExclusion Criteria:\n\n* Age \\<18 years\n* Pregnancy or lactation\n* Known allergic reactions to angiotensin-II or hydrocortisone sodium succinate\n* Requiring \\>25 mcg/min of norepinephrine or on any vasopressor other than norepinephrine at study enrollment\n* Clinically significant bleeding precluding the use of chemical prophylaxis for venous thromboembolism\n* Treatment with another investigational drug or other intervention during study timeframe",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tyson Dietrich, PharmD",
                    "role": "CONTACT",
                    "phone": "928-263-3933",
                    "email": "TDietrich@azkrmc.com"
                },
                {
                    "name": "Anthony Santarelli, PhD",
                    "role": "CONTACT",
                    "phone": "928-757-0649",
                    "phoneExt": "5143",
                    "email": "anthony.santarelli@azkrmc.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Tyson Dietrich, PharmD",
                    "affiliation": "Kingman Regional Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Kingman Regional Medical Center",
                    "status": "RECRUITING",
                    "city": "Kingman",
                    "state": "Arizona",
                    "zip": "86401",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tyson Dietrich, PharmD",
                            "role": "CONTACT",
                            "phone": "928-263-3933",
                            "email": "tdietrich@azkrmc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.18944,
                        "lon": -114.05301
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012772",
                    "term": "Shock, Septic"
                },
                {
                    "id": "D000012769",
                    "term": "Shock"
                },
                {
                    "id": "D000018746",
                    "term": "Systemic Inflammatory Response Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018805",
                    "term": "Sepsis"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000007249",
                    "term": "Inflammation"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M15577",
                    "name": "Shock",
                    "asFound": "Shock",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20864",
                    "name": "Sepsis",
                    "relevance": "LOW"
                },
                {
                    "id": "M16869",
                    "name": "Toxemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M15580",
                    "name": "Shock, Septic",
                    "asFound": "Septic Shock",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20818",
                    "name": "Systemic Inflammatory Response Syndrome",
                    "asFound": "Systemic Inflammatory Response Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10293",
                    "name": "Inflammation",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006854",
                    "term": "Hydrocortisone"
                },
                {
                    "id": "C000033014",
                    "term": "Hydrocortisone 17-butyrate 21-propionate"
                },
                {
                    "id": "C000021650",
                    "term": "Hydrocortisone acetate"
                },
                {
                    "id": "C000007133",
                    "term": "Hydrocortisone hemisuccinate"
                },
                {
                    "id": "D000000804",
                    "term": "Angiotensin II"
                },
                {
                    "id": "C000627694",
                    "term": "Giapreza"
                },
                {
                    "id": "D000000808",
                    "term": "Angiotensinogen"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000014662",
                    "term": "Vasoconstrictor Agents"
                },
                {
                    "id": "D000015842",
                    "term": "Serine Proteinase Inhibitors"
                },
                {
                    "id": "D000011480",
                    "term": "Protease Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9912",
                    "name": "Hydrocortisone",
                    "asFound": "Prescribed",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17409",
                    "name": "Vasoconstrictor Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4132",
                    "name": "Angiotensin II",
                    "asFound": "What is",
                    "relevance": "HIGH"
                },
                {
                    "id": "M289354",
                    "name": "Giapreza",
                    "asFound": "Icing",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4135",
                    "name": "Angiotensinogen",
                    "asFound": "What is",
                    "relevance": "HIGH"
                },
                {
                    "id": "M155245",
                    "name": "Hydrocortisone 17-butyrate 21-propionate",
                    "asFound": "Cell line",
                    "relevance": "HIGH"
                },
                {
                    "id": "M228609",
                    "name": "Hydrocortisone acetate",
                    "asFound": "Cell line",
                    "relevance": "HIGH"
                },
                {
                    "id": "M263259",
                    "name": "Hydrocortisone hemisuccinate",
                    "asFound": "Cell line",
                    "relevance": "HIGH"
                },
                {
                    "id": "M242077",
                    "name": "Hydrocortisone-17-butyrate",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M14343",
                    "name": "Protease Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M18391",
                    "name": "Serine Proteinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19609",
                    "name": "HIV Protease Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T18",
                    "name": "Serine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}